drugset / Trial / NCT00489346

A Study to Evaluate MK0476 and Fluticasone to Control Asthma in Patients With Mild Persistent Asthma (0476-910)

NCT00489346

Phase 3 Completed 994 enrolled Organon and Co
RandomizedParallel-groupDouble-blindTreatment

Summary

A study to evaluate MK0476 and Fluticasone to control asthma in patients with mild persistent asthma.

Timeline

Start
2001-10
Primary completion
2002-06
Completion
2002-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluticasone propionate Other / unclassified Inhaled
Subject Montelukast Other / unclassified Oral

Indications